Bodamer O A, Bloesch S M, Gregg A R, Stockler-Ipsiroglu S, O'Brien W E
Biochemical Genetics Laboratory, Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Clin Chim Acta. 2001 Jun;308(1-2):173-8. doi: 10.1016/s0009-8981(01)00480-6.
Guanidinoacetate methyltransferase (GAMT) deficiency is a disorder of creatine metabolism characterized by low plasma creatine concentrations in combination with elevated guanidinoacetate (GAA) concentrations. Although rare, GAMT deficiency has been identified in children with seizures, extrapyramidal movements, developmental delay, myopathies and behavioral abnormalities. Treatment with creatine monohydrate has been proven to be effective. We describe an isotope dilution electrospray tandem mass spectrometry (ES-MS/MS) assay for the simultaneous determination of plasma GAA and creatine using multiple reaction monitoring (MRM), d(3)-creatine as the internal standard and derivatization of GAA and creatine as butyl-esters. We analysed plasma of 16 healthy adults and 20 healthy children as well as three affected children. Plasma GAA concentrations were 5.02+/-1.84 micromol/l (mean+/-S.D.) in adults, 3.91+/-0.76 micromol/l in children age 5-10 years and 11.57, 15.16, 14.36 micromol/l in children with GAMT deficiency. Plasma creatine concentrations were 34.7+/-15.25 micromol/l in adults, 58.96+/-22.30 micromol/l in children and 5.37, 8.15, 403.5 micromol/l in two untreated children and one treated child with GAMT deficiency, respectively. GAA can also be reliably measured from filter cards, which is sufficient to make the correct diagnosis while creatine is consistently falsely elevated probably secondary to liberation of red cell creatine. In nine healthy newborn infants, GAA concentrations from filter cards were 4.83+/-1.43 and 5.04+/-1.84 micromol/l in 16 healthy adults. We conclude that isotope dilution ES-MS/MS is ideal for rapid high-throughput diagnosis of GAMT deficiency both from plasma and filter paper cards. Using this technique neonatal screening is feasible for this treatable inborn error of creatine metabolism.
胍乙酸甲基转移酶(GAMT)缺乏症是一种肌酸代谢紊乱疾病,其特征为血浆肌酸浓度降低,同时胍乙酸(GAA)浓度升高。尽管罕见,但在患有癫痫、锥体外系运动障碍、发育迟缓、肌病和行为异常的儿童中已发现GAMT缺乏症。已证明使用一水肌酸治疗有效。我们描述了一种同位素稀释电喷雾串联质谱(ES-MS/MS)分析法,该方法使用多反应监测(MRM)、d(3)-肌酸作为内标以及将GAA和肌酸衍生化为丁酯,同时测定血浆GAA和肌酸。我们分析了16名健康成年人、20名健康儿童以及三名患病儿童的血浆。成年人血浆GAA浓度为5.02±1.84微摩尔/升(平均值±标准差),5至10岁儿童为3.91±0.76微摩尔/升,患有GAMT缺乏症的儿童为11.57、15.16、14.36微摩尔/升。成年人血浆肌酸浓度为34.7±15.25微摩尔/升,儿童为58.96±22.30微摩尔/升,两名未经治疗的患有GAMT缺乏症的儿童和一名接受治疗的儿童的血浆肌酸浓度分别为5.37、8.15、403.5微摩尔/升。也可以从滤纸片可靠地测量GAA,这足以做出正确诊断,而肌酸可能因红细胞肌酸释放而持续被错误地升高。在九名健康新生儿中,滤纸片上的GAA浓度为4.83±1.43微摩尔/升,16名健康成年人中为5.04±1.84微摩尔/升。我们得出结论,同位素稀释ES-MS/MS对于从血浆和滤纸卡快速高通量诊断GAMT缺乏症是理想的。使用这种技术,新生儿筛查对于这种可治疗的肌酸代谢先天性错误是可行的。